Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
129.3 USD | -0.59% | +1.35% | +18.59% |
03:02pm | Merck: phase 3 trial in melanoma halted | CF |
02:05pm | Merck Ends Co-Formulation Arm of Keytruda High-Risk Melanoma Study | DJ |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.